Lightspeed Microscopy reimagines pathology by providing a full-stack solution to nondestructively image large tissues in 3D at sub-cellular resolution. Its novel chemistry, patented high-throughput light-sheet microscope, and cloud-based AI analysis software adds a new dimension to pathology.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/15/21 | $4,000,000 | Series A |
Dynamk Capital | undisclosed |
